SAN JOSÉ DEL CABO, MX / ACCESS Newswire / January 13, 2026 / Every year, more patients from the United States, Canada, and around the world travel to Mexico in search of advanced regenerative medicine ...

A near-death trauma and immigrant experience informs Guadalupe Hayes-Mota’s work developing ethical frameworks for all ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

2026 is highlighted as the year of the singularity with Elon Musk warning of underestimated impacts; conversations with him ...

In Gov. Gavin Newsom’s final State of the State address to the California Legislature, he highlights accomplishments, looks ...

The best cyberpunk TV shows paint dark pictures of dystopian futures where technology is a double-edged sword and identity is ...

This company has just won approval to go ahead with a key clinical trial. The post This biotech is approaching 20-bagger ...

While duplicating Fido isn’t quite the ethical minefield that duplicating Uncle Fred would be, it does raise questions on where biotechnology is headed. Tom Brady in West Hollywood, Calif., in 2023 on ...

Guadalupe Hayes-Mota is director, bioethics at the Markkula Center for Applied Ethics. Views are his own. This article, "Using the CARES Framework to Build Ethical Biotech Startups" , originally ...

In my experience, launching a biotech startup is one of the most thrilling and consequential ventures a person can undertake. It combines the drive of entrepreneurship with the weight of human health.